To explore this further, Vituret and colleagues in 2016 investigated the use of MVs and exosomes as carriers to deliver exogenous CFTR glycoprotein and its encoding mRNA to human CF cells, aiming to restore CFTR chloride channel function [34]. Here, CFTR is linked to cystic fibrosis.